BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 29807533)

  • 21. Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response.
    Zhang J; Du M; Li Z; Liu W; Ren B; Zhang Y; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():708704. PubMed ID: 34630325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy.
    López E; Gunby J; Daya S; Parrilla JJ; Abad L; Balasch J
    Reprod Biomed Online; 2004 Oct; 9(4):382-90. PubMed ID: 15511336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.
    Chen Q; Wang Y; Sun L; Zhang S; Chai W; Hong Q; Long H; Wang L; Lyu Q; Kuang Y
    Reprod Biol Endocrinol; 2017 Sep; 15(1):71. PubMed ID: 28870217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study.
    Zhang Y; Li H; Zhu S; Jiang S; Zhao W; Wang X; Tian L; Zhao G; He N; Diao H; Cao H; Zhang C
    Front Endocrinol (Lausanne); 2023; 14():1295787. PubMed ID: 38155955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
    Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
    Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial.
    Wang N; Zhu Q; Ma M; Liang Z; Tao Y; Wang Y; Kuang Y
    BMJ Open; 2020 Dec; 10(12):e038153. PubMed ID: 33268401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment.
    Liu Y; Lin J; Shen X; Zhu Q; Kuang Y
    Front Endocrinol (Lausanne); 2023; 14():1072170. PubMed ID: 36936138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome.
    Mejia RB; Summers KM; Kresowik JD; Van Voorhis BJ
    Fertil Steril; 2019 Mar; 111(3):571-578.e1. PubMed ID: 30683591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for
    Guo H; Li J; Shen X; Cong Y; Wang Y; Wu L; Li B; Gao H; Ma M; Zhang W; Mao X; Fu Y; Lyu Q; Chai W; Kuang Y
    Front Endocrinol (Lausanne); 2020; 11():129. PubMed ID: 32265834
    [No Abstract]   [Full Text] [Related]  

  • 30. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
    Kuang Y; Chen Q; Fu Y; Wang Y; Hong Q; Lyu Q; Ai A; Shoham Z
    Fertil Steril; 2015 Jul; 104(1):62-70.e3. PubMed ID: 25956370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients.
    Hwang JL; Chen SU; Chen HJ; Chen HF; Yang YS; Chang CH; Seow KM; Tzeng CR; Lin YH
    J Formos Med Assoc; 2018 Jun; 117(6):535-540. PubMed ID: 28830648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.
    Kalafat E; Turkgeldi E; Yıldız S; Dizdar M; Keles I; Ata B
    Front Endocrinol (Lausanne); 2022; 13():837880. PubMed ID: 35663329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.
    Zhu X; Ye H; Fu Y
    Medicine (Baltimore); 2016 Jul; 95(28):e4193. PubMed ID: 27428219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.
    Neveu N; Granger L; St-Michel P; Lavoie HB
    Fertil Steril; 2007 Jan; 87(1):113-20. PubMed ID: 17081535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.
    Kao TC; Hsieh YC; Yang IJ; Wu MY; Chen MJ; Yang JH; Chen SU
    J Formos Med Assoc; 2023 Jan; 122(1):29-35. PubMed ID: 36123235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
    Chen Y; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function.
    Xu S; Wang X; Zhang Y; Han Y; Zhang C
    Gynecol Endocrinol; 2023 Dec; 39(1):2217263. PubMed ID: 37236243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extension of the clomiphene citrate stair-step protocol to gonadotropin treatment in women with clomiphene resistant polycystic ovarian syndrome.
    Horowitz E; Levran D; Weissman A
    Gynecol Endocrinol; 2017 Oct; 33(10):807-810. PubMed ID: 28454491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.